EMR - Spark Newswire

1 minute read

Global
News

Emerson Announces Agreement To Divest Its Russia Business To Local Management

Yesterday, 8:08 AM

Emerson (NYSE:EMR) today announced an agreement to sell its Russia business, including Metran, its Russia-based manufacturing subsidiary, and Emerson LLC in Russia, the sales and service organization for Metran, to the

EMR

56 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

September 22, 2:17 PM

On Thursday, 1076 companies hit new 52-week lows.

$APE

1 minute read

Analyst Ratings

Where Emerson Electric Stands With Analysts

By Benzinga Insights

August 16, 2:10 PM

Within the last quarter, Emerson Electric (NYSE:EMR) has observed the following analyst ratings:

EMR

1 minute read

Emerson Electric Price Target Bumped Up By Analysts Post Q3 Results

By Akanksha Bakshi

August 10, 3:32 PM

RBC Capital analyst Deane Dray raised the price target for Emerson Electric Co. (NYSE:EMR) to $102 (an upside of 17%) from $96 while…

EMR

1 minute read

RBC Capital Maintains Outperform on Emerson Electric, Raises Price Target to $102

By Benzinga Newsdesk

August 10, 8:35 AM

RBC Capital analyst Deane Dray maintains Emerson Electric (NYSE:EMR) with a Outperform and raises the price target from $96 to $102.

EMR

2 minute read

Emerson Electric Reports Q3 Sales Growth Of 7%, Raises FY22 EPS Guidance

By Akanksha Bakshi

August 9, 1:17 PM

Emerson Electric Co (NYSE:EMR) reported third-quarter FY22 net sales growth of 7% year-over-year to $5 billion, missing the consensus of $5.12…

EMR

1 minute read

Earnings

Emerson Electric: Q3 Earnings Insights

By Benzinga Insights

August 9, 7:09 AM

Emerson Electric (NYSE:EMR) reported its Q3 earnings results on Tuesday, August 9, 2022 at 06:55 AM. Here's what investors need to know about the announcement.

EMR

1 minute read

Emerson Electric Q3 EPS $1.38 Beats $1.30 Estimate, Sales $5.00B Miss $5.12B Estimate

By Bill Haddad

August 9, 6:59 AM

Emerson Electric (NYSE:EMR) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $1.30 by 6.15 percent. This is a 26.61 percent increase over earnings of $1.09 per share from the

EMR